Glioblastoma (GBM) is the most common and most aggressive brain tumour. Prognosis
remains poor, despite the combined treatment of radio-and chemotherapy following surgical …

Cancer remains a global health challenge, necessitating continuous advancements in
diagnostic and treatment strategies. This review focuses on the utility of non-invasive …

Background: Patients with glioblastoma have a poor prognosis. We want to develop and
validate nomograms for predicting overall survival in patients with glioblastoma. Methods …

Despite their low incidence rate globally, high-grade gliomas (HGG) remain a fatal primary
brain tumor. The recommended therapy often is incapable of resecting the tumor entirely …

Objective Develop a time-dependent deep learning model to accurately predict the
prognosis of pediatric glioma patients, which can assist clinicians in making precise …

Background Promoter methylation of the DNA repair gene O 6-methylguanine-DNA
methyltransferase (MGMT) is an acknowledged predictive epigenetic marker in glioblastoma …

Glioblastoma Multiforme (GBM) is an aggressive brain tumor (WHO grade 4 astrocytoma)
with unknown causes and is associated with a reduced life expectancy. The available …

A single-institution observational study with 43 newly diagnosed diffuse gliomas defined the
isocitrate dehydrogenase 1 and 2 (IDH1/2) gene mutation status and evaluated the …

Glioblastoma (GBM) is the most common primary brain malignancy in adults. Despite
multimodal treatment that involves maximal safe resection, concurrent chemoradiotherapy …

There are several types of brain tumors but glioblastoma (GBM) is one of the highly
malignant tumors. A primary concern with GBM is that the treatment is inadequate. Even …